Np mrd loader

Record Information
Version2.0
Created at2024-02-19 00:00:18 UTC
Updated at2024-09-03 04:19:28 UTC
NP-MRD IDNP0332517
Natural Product DOIhttps://doi.org/10.57994/1771
Secondary Accession NumbersNone
Natural Product Identification
Common NameBrevicidine B
Description Brevicidine B was first documented in 2024 (PMID: 38423998). Based on a literature review a small amount of articles have been published on Brevicidine B.
Structure
Thumb
SynonymsNot Available
Chemical FormulaC74H106N18O16
Average Mass1503.7720 Da
Monoisotopic Mass1502.80342 Da
IUPAC Name(2R)-N-[(1R)-1-{[(1R)-1-{[(1R)-4-amino-1-{[(1S)-4-amino-1-[({[(1R)-4-amino-1-{[(1S)-1-{[(3S,9S,12S,13R)-9-[(2S)-butan-2-yl]-3-(hydroxymethyl)-13-methyl-2,5,8,11-tetraoxo-1-oxa-4,7,10-triazacyclotridecan-12-yl]carbamoyl}-2-(1H-indol-3-yl)ethyl]carbamoyl}butyl]carbamoyl}methyl)carbamoyl]butyl]carbamoyl}butyl]carbamoyl}-2-(1H-indol-3-yl)ethyl]carbamoyl}-2-phenylethyl]-2-(4-methylhexanamido)butanediamide
Traditional Name(2R)-N-[(1R)-1-{[(1R)-1-{[(1R)-4-amino-1-{[(1S)-4-amino-1-[({[(1R)-4-amino-1-{[(1S)-1-{[(3S,9S,12S,13R)-9-[(2S)-butan-2-yl]-3-(hydroxymethyl)-13-methyl-2,5,8,11-tetraoxo-1-oxa-4,7,10-triazacyclotridecan-12-yl]carbamoyl}-2-(1H-indol-3-yl)ethyl]carbamoyl}butyl]carbamoyl}methyl)carbamoyl]butyl]carbamoyl}butyl]carbamoyl}-2-(1H-indol-3-yl)ethyl]carbamoyl}-2-phenylethyl]-2-(4-methylhexanamido)succinamide
CAS Registry NumberNot Available
SMILES
CCC(C)CCC(=O)N[C@H](CC(N)=O)C(=O)N[C@H](CC1=CC=CC=C1)C(=O)N[C@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@H](CCCN)C(=O)N[C@@H](CCCN)C(=O)NCC(=O)N[C@H](CCCN)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@H]1[C@@H](C)OC(=O)[C@H](CO)NC(=O)CNC(=O)[C@@H](NC1=O)[C@@H](C)CC
InChI Identifier
InChI=1S/C74H106N18O16/c1-6-41(3)27-28-60(95)84-57(35-59(78)94)70(103)88-54(32-44-18-9-8-10-19-44)68(101)90-55(33-45-36-79-49-22-13-11-20-47(45)49)69(102)87-53(26-17-31-77)67(100)86-51(24-15-29-75)65(98)81-38-61(96)83-52(25-16-30-76)66(99)89-56(34-46-37-80-50-23-14-12-21-48(46)50)71(104)92-64-43(5)108-74(107)58(40-93)85-62(97)39-82-72(105)63(42(4)7-2)91-73(64)106/h8-14,18-23,36-37,41-43,51-58,63-64,79-80,93H,6-7,15-17,24-35,38-40,75-77H2,1-5H3,(H2,78,94)(H,81,98)(H,82,105)(H,83,96)(H,84,95)(H,85,97)(H,86,100)(H,87,102)(H,88,103)(H,89,99)(H,90,101)(H,91,106)(H,92,104)/t41?,42-,43+,51-,52+,53+,54+,55+,56-,57+,58-,63?,64?/m0/s1
InChI KeyAIBWBLZSMXDYHS-HOFMNPNYSA-N
Experimental Spectra
Spectrum TypeDescriptionDepositor EmailDepositor OrganizationDepositorDeposition DateView
NOESY NMR[1H, 1H] NMR Spectrum (2D, 500 MHz, C2D6OS, experimental)dpal969@aucklanduni.ac.nzThe University of AucklandDennise Palpal-latoc2024-02-19View Spectrum
1D NMR13C NMR Spectrum (1D, 126 MHz, C2D6OS, experimental)dpal969@aucklanduni.ac.nzThe University of AucklandDennise Palpal-latoc2024-02-19View Spectrum
HSQC NMR[1H, 13C] NMR Spectrum (2D, 500 MHz, C2D6OS, experimental)dpal969@aucklanduni.ac.nzThe University of AucklandDennise Palpal-latoc2024-02-19View Spectrum
TOCSY NMR[1H, 1H] NMR Spectrum (2D, 500 MHz, C2D6OS, experimental)dpal969@aucklanduni.ac.nzThe University of AucklandDennise Palpal-latoc2024-02-19View Spectrum
HSQC NMR[1H, 15N] NMR Spectrum (2D, 500 MHz, C2D6OS, experimental)dpal969@aucklanduni.ac.nzThe University of AucklandDennise Palpal-latoc2024-02-19View Spectrum
COSY NMR[1H, 1H] NMR Spectrum (2D, 500 MHz, C2D6OS, experimental)dpal969@aucklanduni.ac.nzThe University of AucklandDennise Palpal-latoc2024-02-19View Spectrum
1D NMR1H NMR Spectrum (1D, 500 MHz, C2D6OS, experimental)dpal969@aucklanduni.ac.nzThe University of AucklandDennise Palpal-latoc2024-02-19View Spectrum
Predicted Spectra
Not Available
Chemical Shift Submissions
Not Available
Species
Species of OriginNot Available
Chemical Taxonomy
ClassificationNot classified
Physical Properties
StateNot Available
Experimental Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Predicted Properties
PropertyValueSource
logP-3.7ChemAxon
pKa (Strongest Acidic)10.53ChemAxon
pKa (Strongest Basic)9.97ChemAxon
Physiological Charge3ChemAxon
Hydrogen Acceptor Count18ChemAxon
Hydrogen Donor Count19ChemAxon
Polar Surface Area548.46 ŲChemAxon
Rotatable Bond Count41ChemAxon
Refractivity393.84 m³·mol⁻¹ChemAxon
Polarizability156.47 ųChemAxon
Number of Rings6ChemAxon
BioavailabilityNoChemAxon
Rule of FiveNoChemAxon
Ghose FilterNoChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleYesChemAxon
HMDB IDNot Available
DrugBank IDNot Available
Phenol Explorer Compound IDNot Available
FoodDB IDNot Available
KNApSAcK IDNot Available
Chemspider IDNot Available
KEGG Compound IDNot Available
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkNot Available
METLIN IDNot Available
PubChem CompoundNot Available
PDB IDNot Available
ChEBI IDNot Available
Good Scents IDNot Available
References
General References
  1. Palpal-Latoc D, Horsfall AJ, Cameron AJ, Campbell G, Ferguson SA, Cook GM, Sander V, Davidson AJ, Harris PWR, Brimble MA: Synthesis, Structure-Activity Relationship Study, Bioactivity, and Nephrotoxicity Evaluation of the Proposed Structure of the Cyclic Lipodepsipeptide Brevicidine B. J Nat Prod. 2024 Apr 26;87(4):764-773. doi: 10.1021/acs.jnatprod.3c00876. Epub 2024 Feb 29. [PubMed:38423998 ]